Roche Wins FDA Clearance for Elecsys pTau217 Test
INDIANAPOLIS, U.S., Aug 28, 2026 Roche has received U.S. FDA clearance for Elecsys® Phospho-Tau (217P) Plasma (pTau217), a blood-based...
FDA clearance
Advertisement
Masimo Gains FDA Clearance for Continuous Oxygen Delivery Monitoring
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
Quest Diagnostics Adds Roche pTau217 Blood Test to AD Portfolio
Secaucus, New Jersey, August 24, 2026 Quest Diagnostics announced new developments in its Quest AD-Detect® blood-testing portfolio, expanding access...
Implantica Wins FDA Approval for RefluxStop® in U.S.
Stockholm, Sweden, August 21, 2026 Implantica AG has announced a major U.S. regulatory milestone after the U.S. Food and...
C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing
NEW YORK, August 21, 2026 The U.S. Food and Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2 blood test,...
Advertisements
Maverix Medical Advances Lung Cancer Diagnosis With Narwhal
Menlo Park, California, August 20, 2026 Maverix Medical has announced that the U.S. Food and Drug Administration (FDA) granted...
Hyperfine Gains FDA Clearance for Next Optive AI Software
Guilford, Connecticut, August 20, 2026 Hyperfine announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s...
Aqua Medical Advances PIMA Trial for Type 2 Diabetes
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
Resivant Medical Advances Cutiva PLUS in First Human Use
AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...
Kandu Reports Positive IpsiHand BCI Stroke Trial Results
VAN NUYS, Calif., August 18, 2026 Kandu, Inc. announced the publication of results from BCI-REHAB, the first randomized controlled...
Advertisement
